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Disproportionate cardiac hypertrophy during early postnatal
development in infants born preterm
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BACKGROUND: Adults born very preterm have increased
cardiac mass and reduced function. We investigated whether
a hypertrophic phenomenon occurs in later preterm infants
and when this occurs during early development.
METHODS: Cardiac ultrasound was performed on 392 infants
(33% preterm at mean gestation 34 ± 2 weeks). Scans were
performed during fetal development in 137, at birth and
3 months of postnatal age in 200, and during both fetal and
postnatal development in 55. Cardiac morphology and
function was quantified and computational models created
to identify geometric changes.
RESULTS: At birth, preterm offspring had reduced cardiac
mass and volume relative to body size with a more globular
heart. By 3 months, ventricular shape had normalized but both
left and right ventricular mass relative to body size were
significantly higher than expected for postmenstrual age (left
57.8 ± 41.9 vs. 27.3 ± 29.4%, Po0.001; right 39.3 ± 38.1 vs.
16.6 ± 40.8, P= 0.002). Greater changes were associated with
lower gestational age at birth (left Po0.001; right P= 0.001).
CONCLUSION: Preterm offspring, including those born in late
gestation, have a disproportionate increase in ventricular mass
from birth up to 3 months of postnatal age. These differences
were not present before birth. Early postnatal development
may provide a window for interventions relevant to long-term
cardiovascular health.
Worldwide, ~ 1 in 10 infants are born preterm, and owingto improved maternal–fetal and neonatal intensive care
the majority now survive to adulthood (1). However, this
survival may be at the expense of long-term cardiovascular
sequelae. Birth triggers a switch in cardiomyocytes from a
fetal hyperplastic to hypertrophic growth pattern (2,3). In
experimental preterm models, exposure of immature cardio-
myocytes to the high-resistance, relatively hyperoxic, post-
natal, arterial circulation results in their significant
hypertrophy (2,3). This may also occur in humans, as adults
born preterm have a unique cardiac shape, as well as
significantly increased cardiac mass (4). Furthermore, the
severity of the changes in adulthood are proportional to the
degree of prematurity (4,5), and can be modified by exposures
during this early developmental period (6,7).
To test the hypothesis that there is evidence of postnatal
changes to cardiac performance in response to the ex utero
environment in the preterm infant, we performed serial
echocardiograms at birth and 3 months of age to assess
differences in maturational patterns of cardiac structure and
function between preterm and term infants. We then
compared the changes in cardiac mass, volumes, and shape
with those expected during term pregnancies from early
gestation, taking account of variation in body growth and
other perinatal factors.
METHODS
Study Overview
Between 2011 and 2015, mothers being cared for by the Oxford
University Hospitals NHS Foundation Trust were identified by their
clinical care team and invited to take part in one or more of a
portfolio of studies coordinated by the Oxford Cardiovascular
Clinical Research Facility. These studies were designed to investigate
the impact of pregnancy complications on cardiovascular develop-
ment during gestation and after birth.
Neonatal Cohort Selection and Imaging Assessments
A stratified recruitment approach to ensure balanced representation
of preterm and term birth, as well as hypertensive and normotensive
pregnancies, was used through the EPOCH (Effect of Preterm birth
and pregnancy Hypertension on Offspring Cardiovascular Health)
study (South Central Berkshire Research Ethics Committee ref. 11/
SC/0006, UKCRN/clinical trials ref. NCT01888770) (8). On
designated days of the week, consecutive women who had delivered
preterm and/or who had experienced a hypertensive pregnancy were
approached to take part in the study. A subgroup of women who had
experienced a term, normotensive pregnancy delivering on the
same day were also approached to serve as a control group. In
total, 255 infants were recruited to the neonatal cohort and
underwent echocardiography soon after birth and at 3 months of
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age (Figure 1). The phenotypic switch in cardiomyocytes is thought
to take place in the first two weeks of postnatal development (9). We
therefore chose 3 months of age as the timing for our follow-up
assessment, as at this point even the most preterm in our cohort
would be a few weeks post term-equivalent age. The majority of
preterm infants studied were born moderate to late preterm, between
32 and 36 weeks (102/121= 84%).
Fetal Cohort Selection and Imaging Assessments
The final 55 mothers from our neonatal cohort were recruited
antenatally and fetal echocardiography performed starting at
15 weeks of gestation and at multiple time points until delivery
(Figure 1). Fetal echocardiography was also performed in a cohort of
137 uncomplicated pregnancies within the INTERBIO-21st study
(South Central—Oxford C Research Ethics Committee ref. 08/
H0606/139). This was a longitudinal study in which women were
attended every 4 weeks during pregnancy for an obstetric ultrasound
scan. On designated days, all mothers attending an assessment had
fetal echocardiography performed as part of their scan. Therefore,
some fetuses underwent multiple echocardiograms, whereas others
only had measurements at a single time point. Of the n= 192 fetuses
scanned, 110 fetuses were scanned once; 43 were scanned twice; 21
were scanned three times; 12 were scanned four times; and six were
scanned five times.
All mothers gave written informed consent and assent for
involvement of their children, including permission to access
maternal and offspring clinical records. Singletons and multiples
were included. Mothers below the age of 16 years were excluded from
the study as were those with chronic cardiovascular conditions
prenatally, including hypertension, although those who suffered from
hypertensive disorders of pregnancy were included. Infants were
excluded if they had evidence of any severe malformations,
congenital cardiovascular disease, chromosomal abnormalities, or
genetic disorders, but those with persistent features of a fetal
circulation at birth, i.e., patent ductus arteriosus (PDA) and/or atrial
septal defect (ASD), were included.
Anthropometric and Blood Pressure Measurements
Gestational age at the time of measurements was calculated relative
to gestational age defined at first trimester ultrasound. At both the
birth and 3-month assessments, weight was measured using digital
scales (Charder Model MS4200) to the nearest 0.01 kg with the infant
fully naked. During gestation, head circumference was taken from a
cross-sectional view of the fetal head at the level of the thalami as
close as possible to the horizontal as previously described (10) and
the average of three measurements used. Postnatally, head
circumference was measured with a tape measure to the nearest
millimeter. Z-scores for weight were calculated using the interna-
tional standard size at birth reference charts from the
INTERGROWTH-21st Project (11,12) using their online application
(https://intergrowth21.tghn.org/global-perinatal-package/inter
growth-21st-comparisonapplication/).
Data collection methods and clinical characterization have
previously been reported (8) and are included in the
Supplementary Methods online.
Echocardiography
Fetuses were scanned on a Philips HD9 with a C6-3 curved-array
transducer. At birth, a Phillips CX50 was used with a 3-month
follow-up on a Philips iE33 with an S12-4 transducer. At each time
point, a 2D transthoracic echocardiography protocol that included
acquisition of a four-chamber view optimized for the LV was
performed according to standard guidelines (13). Postnatal measures
were performed in a temperature-controlled room, with the infant at
rest in a semi-recumbent position at 45 degrees, either in their
mother’s arms or in a crib. Frame rates were maximized and multiple
images were acquired for off-line selection of high-quality loops.
Standard methods for quantification of volume and mass of the left
ventricle were performed (14) based on linear measures of wall
thickness using standard approaches (15). In addition, we used
TomTec Image Arena 4.6 to create automated estimates of LV mass
based on endocardial and epicardial borders defined in multiple
four-chamber cine loops. An adaptation of the method was applied
to the RV, as previously reported (16). Body size correction for
measures during gestation and in analyses from gestation through
postnatal development was based on adjustment for head circum-
ference, as this provided a directly quantified indicator of growth,
known to be accurate in the antenatal and postnatal period (17). In
addition, for neonatal measures, ventricular mass and volumes were
adjusted for body size based on estimated body surface area, using
the Boyd formula (18), and these values are reported as mass or
volume index. Morphology of the LV in the four-chamber view was
analyzed by construction of a computational statistical shape model,
through adaptation of a technical approach previously described for
magnetic resonance images (19,20). Detailed methods and our
laboratory inter- and intra-observer variability for measures are
described in the Supplementary Methods.
Investigators performing the assessments were not blinded to
participant group, but those involved in image analysis were.
Statistical Analysis
Statistical analysis was performed using SPSS Version 20 (IBM,
Armonk, New York, NY) and GraphPad Prism Version 6.0 (La Jolla,
CA). In addition, STATA, Version 11.2, software (StataCorp LP,
College Station, TX) was used to analyze developmental trajectories
and cardiac shape analysis was performed with Matlab (Mathworks,
Natick, MA). Values are presented as mean± SD unless stated
otherwise.
To compare mean differences in cardiac size postnatally, Student’s
t-test and Mann–Whitney U test were used as appropriate. Tests of
associations were performed using the χ2 test. Linear regression
models were performed with a forced entry method. Pearson
correlations (r) were used for bivariate associations, and
Fetal studies
n=192
Postnatal studies
n=255
n=55
(n=10 preterm;
n=45 term)
n=55
(n=10 preterm;
n=45 term)
n=137
(n=7 preterm;
n=130 term)
n=200
(n=111 preterm;
n=89 term)
Figure 1. Flow diagram of study recruitment. A total of 392 individuals
took part in the study for echocardiography imaging. One hundred and
ninety two individuals were recruited during gestation (fetal studies) to
undergo echocardiography scans, with n=55 (n=10 preterm; n= 45
term, shown in teal) going on to take part in the postnatal studies. An
additional n= 200 individuals were recruited at birth (shown in dark
blue) to take part in birth and 3-month postnatal age echocardiography
scans (total n=255 postnatal studies, n=121 preterm; n= 134 term).
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unstandardized regression coefficients (B) were used for bivariate
and multivariate regression models. Variables were selected from
bivariate regression models to be included in multivariate regression
models. The sample size n= 134 for term offspring and n= 121
preterm offspring provided us with 80% power at a significance level
of α= 0.05 to detect a difference of at least 0.38 SDs between groups.
To further explore the timing of mass and volume changes in
preterm infants, we studied trajectories of cardiac development using
the combined data set of echocardiographic measures of LV and RV
mass at different time points during gestation and postnatal
development. As volumes pre- and postnatally would not be
comparable because of circulatory changes at birth, we limited
combined gestation and postnatal analyses to mass. Smoothed
centiles of right and left ventricular mass, left and right EDV, and
ratio of mass as a function of HC according to gestational age were
constructed using fractional polynomials. To account for body size
differences between preterm and term infants at different time
points, we adjusted the left and right ventricular mass for head
Table 1. Maternal, fetal, and postnatal characteristics of neonatal cohort
Preterm (n= 121) Term (n=134)
Maternal demographics and anthropometrics
Maternal age at delivery, mean (SD), years 33 (5.7) 32.3 (5.3)
Body mass index at booking, mean (SD), kg/m2 25.5 (5.1) 25.7 (6.8)
Smokers, n (%) 7 (5.8) 4 (3)
Maternal hypertension during pregnancy, n (%) 70 (58) 81 (60)
Maternal diabetes, n (%) 4 (3.3) 8 (6)
Offspring birth characteristics
Gestational age at delivery, mean (SD), weeks 33.9 (2.2) 39.4 (1.3)
Male, n (%) 60 (50) 59 (44)
Birth order, median (IQ range) 1 (1) 1 (1)
Antenatal steroids, n (%) 93 (77) 1 (0.7)†
Cesarean section, n (%) 77 (64) 36 (27)
Apgar score at 5 min, median (IQ range) 10 (1) 10 (0)†
Birthweight, mean (SD), g 2053 (587) 3315 (563)†
Birthweight z-score, mean (SD) − 0.38 (1.1) 0.16 (1.1)†
Small for gestational age, n (%) 21 (17) 20 (15)
Days of ventilation, mean (SD) 0.63 (3.1) 0 (0)†
Ventilated/oxygen therapy for 428 days, n (%) 8 (6.6) 0 (0)†
Given surfactant, n (%) 7 (5.8) 0 (0)†
Treated patent ductus arteriosus (PDA), n (%) 3 (2.5) 0 (0)**
Sets of twins, n (%) 6 (9.2) 1 (1.5)**
Offspring physiological measures at birth assessment (n= 106) (n= 121)
Age at assessment, mean (SD), days 6.6 (5.4) 4 (5.5)†
Weight, mean (SD), g 2053 (587) 3315 (563)†
Body surface area, mean (SD), m2 0.16 (0.03) 0.23 (0.03)†
Head circumference, mean (SD), cm 30.7 (2.4) 34.5 (1.6) *
sBP, mean (SD), mm Hg 74.1 (14.7) 81.6 (13.4)†
dB, mean (SD), mm Hg 40.9 (9.9) 45.1 (9.4)†
Offspring physiological measures at 3-month assessment (n= 106) (n= 123)
Age at assessment, mean (SD), days 99.1 (15.1) 98 (13.8)
Weight, mean (SD), g 4960 (967) 6051 (894)†
Body surface area, mean (SD), m2 0.30 (0.04) 0.35 (0.04)†
Head circumference, mean (SD), cm 39.1 (2.1) 40.8 (1.7)†
sBP, mean (SD), mm Hg 93.7 (12.2) 96.8 (12.4)
dBP, mean (SD), mm Hg 50 (12.4) 54.4 (12.2)**
*Po0.05; **Po0.01; †Po0.001 for comparison between term and preterm.
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circumference (i.e., left ventricular mass/HC) on the basis that this
measure would be the most consistently and accurately quantifiable
body measure throughout gestation and postnatal development
rather than weight or body surface area. This is because weight
cannot be directly or accurately measured in gestation and therefore
pre- and postnatal values cannot be directly compared. In addition,
equations for body surface area have not been validated for fetuses.
Where appropriate, we applied a multilevel, linear regression analysis
to account for repeated measures (21), but there were no significant
differences when compared with analyses that did not account for
the hierarchy of the data. LV and RV mass, volume, and ratio of
mass as a function of HC exhibited a non-normal distribution;
therefore, the data were log-transformed (natural log) to stabilize
variance and transform the data to normality. Goodness-of-fit
assessment incorporated a visual inspection of the quantile–quantile
(q–q) plot of the residuals, and a plot of fitted z-scores across
gestational ages.
Analysis of shape variation between preterm and term infants was
performed by a non-paired t-test. Shape differences were first tested
in each Principal Component Analysis mode under three conditions:
(1) at birth, (2) at follow-up, or (3) by their growth. Then, the
Principal Component Analysis modes, which accounted for the most
variation within the experimental sample, were combined through a
LDA in an attempt to identify the morphological signature of a
premature birth. Cross-validation (leave-1 out) was used to test the
generality of differences found in the LDA, and to select the optimal
Table 2. Cardiac structure and function at birth and 3-month assessment
Birth Follow-up
Preterm Term Preterm Term
Left ventricle
Volumes n=93 n= 118 n=101 n=111
EDV, mean (SD), ml 2.7 (1) 4.2 (1.2)† 8.3 (2.1) 9.2 (2)**
EDV index, mean (SD), ml/m2 16.8 (5.5) 18.5 (4.3)** 27.6 (5.8) 26.8 (5)
ESV, mean (SD), ml 1.1 (0.4) 1.6 (0.7)† 3.5 (1) 3.7 (1)
ESV Index, mean (SD), ml/m2 7 (2.4) 6.8 (2.6) 11.7 (3.3) 10.9 (2.7)
Mass
IVS diameter, mean (SD), cm 0.33 (0.08) 0.39 (0.08)† 0.44 (0.08) 0.43 (0.08)
PWd, mean (SD), cm 0.29 (0.06) 0.30 (0.07) 0.38 (0.07) 0.35 (0.06)**
Mass, mean (SD), g 3.1 (1) 4.7 (1.2)† 8.6 (1.7) 8.9 (1.8)
Mass Index, mean (SD), g/m2 18.8 (3.9) 20.7 (3.9)** 29.2 (6.5) 26 (4.8)†
Mass/EDV, mean (SD) 1.2 (0.3) 1.2 (0.2) 1.1 (0.3) 1 (0.2)**
Function
Systolic function n=72 n=95 n=62 n= 66
Ejection fraction, mean (SD), % 59 (80) 64 (8)† 58 (7) 60 (8)
Stroke volume, mean (SD), ml 1.7 (0.7) 2.7 (0.7)† 4.8 (1.2) 5.7 (1.5)†
Diastolic function n=95 n= 122 n=90 n=109
EA, mean (SD) 1 (0.2) 1 (0.3) 1.1 (0.2) 1 (0.2)
Lateral E′, mean (SD) 6.1 (1.8) 6.6 (1.7)* 9.4 (2.3) 10.2 (2.2)*
Lateral E/E′ ratio, mean (SD) 8.5 (2.5) 7.9 (2.5) 10.1 (2.7) 9.4 (2.7)*
Right ventricle
Volumes n=51 n=76 n=67 n= 75
EDV, mean (SD), ml 1.9 (0.9) 3.4 (1.5)† 4.7 (2) 5.3 (1.8)
EDV Index, mean (SD), ml/m2 11.1 (4.4) 14.7 (5.7)† 15.4 (5.7) 15.2 (4.4)
Mass
Mass, mean (SD), g 2.8 (1.2) 4.1 (1.2)† 6.5 (2.2) 6.8 (1.8)
Mass Index, mean (SD), g/m2 16.3 (5.6) 17.9 (4.3) 21.5 (6.2) 19.3 (4.5)*
Mass/EDV, mean (SD) 1.6 (0.6) 1.4 (0.5)* 1.5 (0.5) 1.4 (0.6)*
Function n=83 n= 118 n=92 n=117
TAPSE, mean (SD) 0.7 (0.2) 0.9 (0.2)† 1.4 (0.3) 1.5 (0.3)**
Ejection fraction, mean (SD), % 49 (12) 51 (8) 56 (13) 56 (13)
*Po0.05; **Po0.01; †Po0.001 for comparison between term and preterm at each time point.
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set of Principal Component Analysis modes to be combined to
differentiate groups.
P-valueso0.05 were considered statistically significant.
RESULTS
Cohort Characteristics
Maternal and offspring demographic and anthropometric
characteristics in the preterm and term groups are presented
in Table 1. Characteristics between groups and available data
sets were similar and are described in full in Supplementary
Table S1.
Postnatal Increase in Ventricular Mass in Preterm-Born Infants
Infants born preterm had a smaller left ventricle (LV) mass
and end-diastolic volume (EDV), indexed to body surface
area, at birth compared with those born at term (Table 2). As
the reduction was proportional, mass/EDV ratio was similar
between groups, suggesting a smaller, but structurally similar,
heart compared with those born at term. However, after
3 months, EDV index in those born preterm was similar to
term-born infants, whereas left ventricular mass index,
indexed to either body surface area or EDV, had become
significantly greater (Table 2), with the percentage postnatal
mass change in the preterm group being double that of the
term group (change in LV mass index (LVMI) 57.8± 41.9 vs.
27.3± 29.4%, Po0.001). These volumetric mass changes were
supported by the linear measures based on posterior wall
thickness (PWd) and associated formulaic mass estimates (15)
(Table 2), which also increased twofold compared with term
counterparts (159.1± 94.8 vs. 94.5± 58.2%, Po0.001).
Preterm neonates already had an increased right ventricle
(RV) mass/EDV ratio at birth (Table 2) but also showed a
twofold greater increase in RV mass index (39.3± 38.1 vs.
16.6± 40.8%, P= 0.002). Changes in LVMI and RV mass
index (RVMI) were proportional to gestational age at birth
(for LVMI r=− 0.49, Po0.001 and RVMI r=− 0.37
P= 0.001, Figure 2a), which was the main predictor of
mass change in multivariate models that had included
maternal pregnancy hypertension, birthweight z-score,
5 min Apgar score, and mode of delivery. In addition,
although birthweight z-score was significantly positively
correlated with gestational age, it was an independent
predictor of LV mass change (Supplementary Tables S2
and S3). Similar patterns of mass change were seen in both
genders. Interestingly, babies born by cesarean sections had
lower Apgar scores across gestation (Po0.001) and for the
preterm group alone (P= 0.003). Both parameters were
associated with mass change, although neither were
significant in multivariable models (Supplementary Tables
S2 and S3). Antenatal steroid exposure was excluded from
multivariate regression models of LVMI and RVMI because of
the significant co-linearity with prematurity. However, in a
multivariate regression analysis with gestational age and
antenatal steroids as the independent variables and change in
LVMI as the dependent variable within the preterm group,
gestational age remained highly significant (P= 0.001),
whereas exposure to antenatal steroids was not significant
(P= 0.67). Similarly, for RVMI, gestational age remained
significant (P= 0.03), whereas exposure to antenatal steroids
was not significant (P= 0.93). Furthermore, we have
performed a subgroup analysis in our preterm group for
LVMI and RVMI at birth and 3 months of postnatal age to
compare those who were (n= 93) and were not (n= 28)
exposed to antenatal steroids (Supplementary Table S4).
These results indicate that there are no differences related to
antenatal steroid exposure.
Mass Change Relative to Normal Fetal to Neonatal Cardiac
Growth Trajectories
We then compared cardiac mass in preterm infants with
expected trajectories during the first 12 months of post-
menstrual age. We overlaid the preterm trajectories onto one
built from our fetal and neonatal echocardiographic measures
from uncomplicated pregnancies (Figure 2b). All preterm
measures at birth fell below the 95th centile for expected
cardiac mass based on gestational age with mean z-scores
within the group modeled from the expected cardiac fetal
mass being − 0.16± 0.53 for the LV and − 0.13± 0.50 for the
RV. By follow-up, however, several of the preterm infants
were exceeding the 95% centile for cardiac mass with an
absolute difference in the 50th centile at 49 weeks of
postmenstrual age (3 months of postnatal age for a baby
born at term) between preterm and term LV mass being
1.61 g. To allow for the change in body size during this period,
we additionally created trajectories based on mass indexed to
head circumference as a consistent measure between gestation
and postnatal development (17) and demonstrated similar
patterns (Figure 2c).
Altered Left and Right Ventricular Systolic and Diastolic
Function
There was a reduced LV stroke volume and ejection fraction
at birth in the preterm group related to both the reduction in
EDV index and an increase in end-systolic volume (ESV)
index. LV stroke volume, but not ejection fraction, remained
reduced at 3 months of age (Table 2 and Figure 3a). In the
right ventricle, RV systolic function, as measured by tricuspid
annular plane systolic excursion (TAPSE), was reduced at
both birth and 3 months in the preterm group (Table 2 and
Figure 3b). At birth, there was a significant reduction in
lateral E′ but not E/E′ in preterm infants, but by 3 months of
age there was evidence of reduced relaxation with a
significantly increased lateral E/E′ (Table 2 and Figure 3c).
Interestingly, this increase was proportional to the increase in
LVMI between birth and 3 months in this group (r= 0.21
P= 0.01).
Shape Changes During Postnatal Development
Ventricular shape analysis suggested a unique preterm cardiac
developmental pattern. The major mode that differentiated
groups was, as expected, a general size mode (Figure 4a—
mode 1). Therefore, to study specific shape changes, this
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mode was removed from analysis and linear discriminant
analysis (LDA) was used based on the next five modes (modes
2–6). These accounted for the remainder of the variation
between groups beyond which the addition of further modes
did not increase the area under the curve for differentiation
between groups. Modes 2–6 also all persisted in the cross-
validation test (Figure 4b), and collectively they described
variation between a ‘globular’ and a ‘conical’ heart
(Figure 4c). At birth, the preterm heart tended to be more
globular with a slightly narrower mitral annulus relative to
mid-ventricular width (Po0.001), but this difference between
groups had disappeared by 3 months of age (P= 0.24).
DISCUSSION
This study shows for the first time that preterm infants have a
greater increase in both LV and RV mass over the first three
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postnatal months that is disproportionate to increases in body
and total cardiac size. Indeed, average cardiac mass changes
are double that of their term-born counterparts during this
period. Furthermore, there is a reduction in LV diastolic
function with a persistent reduction in RV systolic function in
the preterm infants. Finally, the hypertrophic patterns and
global dysfunction are postnatal processes that are not evident
during gestation or at birth, but rather emerges during the
early postnatal period.
Previous Studies
The increase in ventricular mass at 3 months of age is
strikingly similar to our previous reports in adults born
preterm (4,5) and increased intraventricular septal thickness
in children born preterm (22). Our longitudinal measures
during postnatal development indicate that this pattern is not
evident at birth but emerges during the early postnatal period.
Some studies report ‘term-equivalent’ comparisons rather
than post-delivery age, but we were able to model data from
early gestation instead, which confirmed the postnatal pattern
of increased mass. In fact, the 0.3 g difference in LV mass
between groups at 3 months of age was substantially smaller
than the 1.6 g difference between the two modeled 50th
centiles at 49 postmenstrual weeks, suggesting that if we had
used ‘term-equivalent’ ages, greater differences may have been
seen between groups. However, longitudinal follow-up is
required to confirm this.
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reduced in preterm (right) compared with term (left) infants at both birth and 3 months of age. (c) Examples of lateral mitral valve annular Tissue
Doppler Imaging measures of early diastole velocities (E′) in term (left) and preterm (right) infants with corresponding pulsed-wave Doppler mitral
valve inflow (E/A ratio). Lateral E′ is decreased and lateral E/E′ increased in preterm infants at 3 months of age. Error bars represent the standard
error of the mean. *Po0.05; **Po0.01; †Po0.001.
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Our observations are consistent with findings from a
preterm-born sheep model, which had a five- to sevenfold
increase in cardiomyocyte hypertrophy during postnatal
development, as well as altered interstitial myocardial fibrosis
and cardiomyocyte maturation (2). Similarly, a rat model of
preterm birth conditions demonstrated increased left ven-
tricular hypertrophy during the postnatal period and,
furthermore, that these changes progressed to heart
failure later in life when challenged with low-dose
angiotensin II infusion and exposure to hypertension (3).
Those born preterm display postnatal catch-up growth (23),
but neither indexing for body size nor cardiac volume
attenuated the large increase in cardiac mass in the preterm-
born infants.
Our measures of mass at birth were similar to levels
previously reported in babies of similar size, born at different
gestations (24–27), and in our preterm cohort were both
proportional to ventricular size and within normal ranges for
postmenstrual age on our fetal nomograms. Therefore, fetal
influences on cardiac development in our preterm population
are subtle. However, at birth, indexed LV mass tended to be
slightly lower than that expected for postmenstrual age and
compared with term-born infants, whereas indexed RV mass
was slightly greater. This may relate to the use of indexing
based on weight formulae, which avoid inaccuracies in length
measurement, but tend to overcorrect in smaller infants (28).
Alternatively, cardiac size differences may reflect the devel-
opmental stage of the preterm infant at birth. The right
ventricle is dominant in utero and is thicker walled than the
LV in fetuses up to 2.7 kg in weight (16,29). Our preterm
cohort had an average birthweight of 2.1 kg, and therefore
may still have a more prominent RV. This could also explain
the differences in cardiac shape at birth as, although globular-
shaped LVs are associated with severe intrauterine growth
restriction (30), this complication was not evident in our
cohort. Shape changes had normalized by 3 months consistent
with the known postnatal reduction in RV dominance. Our
differences in TAPSE measures between preterm and term
infants at birth and 3 months of postnatal age suggest
reductions in RV longitudinal function (31). However, RV
ejection fraction, which reflects global RV systolic function,
did not differ between groups at either time point. It is
possible that RV longitudinal functional changes emerge first,
which may progress to global RV systolic reductions later in
life (4).
Influence of Other Perinatal Factors
Other perinatal factors linked with preterm birth might have
influenced our findings. The use of antenatal steroids was not
included in multivariable analyses because of the significant
co-linearity with preterm birth. However, although we cannot
be sure of an independent effect on mass, our results suggest
that degree of prematurity, rather than antenatal steroids, has
a more substantial contribution to the observed changes in
cardiac mass. Multivariable analyses highlighted a small
independent influence of birthweight z-score on the LV,
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Figure 4. Ventricular shape in preterm versus term-born infants. (a) Significant shape differences between term (green) and preterm (blue) infants
at birth are mainly accounted for by ventricular size (mode 1 in principal component analysis) with convergence by 3 months of age. (b) Linear
discriminant analysis (LDA) identifies five further modes (modes 2–6), which account for the majority of shape variation independent of size between
term and preterm infants. These describe variation between a “globular” and “conical”-shaped ventricle. Further modes did not significantly increase
the area under the curve (AUC), confirmed by cross-validation (leave one out). Blue arrows indicate combination of modes 2–5 and red arrows 2–6.
(c) Shape variations (mode 2–6) at birth between term and preterm infants persist after size adjustment and, again, are reduced by 3 months of
age. Brown and purple contours demonstrate ± 3 SDs from mean. Colored dots indicate relative placing of groups within shape range (term—green,
preterm—blue). *Po0.05; **Po0.01; †Po0.001.
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consistent with a previous finding of mass increase propor-
tional to birth size in very preterm infants (23). Maternal
hypertension was associated with RV mass, which requires
further investigation, but this effect was not significant in the
multivariable model. The associations between mass, birth by
cesarean section, and a low Apgar score are intriguing.
Although, again, these variables were not significant in
multivariable analyses, it might be hypothesized that these
babies were exposed to in utero hypoxia, which has been shown
to cause cardiac remodeling in animal models (32). Blood
pressures in the cohort were appropriate for gestational age
(33) and slightly lower at 3 months in the preterm group and
therefore could not explain the hypertrophy. As previously
observed (25,34), we found that LV systolic function is reduced
at birth in those born preterm but that LV ejection fraction had
normalized by 3 months (35). The myocardium in preterm
models has reduced myocardial contractile elements and
inefficient myofibril shortening due to differences in calcium
homeostasis (36). Therefore, it is possible that the increase in
mass is partly a physiological compensation for reduced
myocardial systolic performance (37).
Multiples were not excluded in this study. It is known that
twins are at an increased risk of congenital heart disease, in
particular in monozygotic pairs (38). Of the six preterm sets
of twins, all were dizygotic except for one monozygotic pair. It
is thus unlikely that these pairs would alter our findings. It is
plausible that other known risk factors of cardiac hypertrophy
that are more common in preterm infants born o32 weeks
gestation, such as maternal diabetes, respiratory distress
syndrome, and patent ductus arteriosus, would have led to
even greater changes in cardiac mass. We were unable to
assess the impact of these confounding factors given their low
prevalence in our cohort of primarily moderate to late
preterm infants. By studying primarily moderate and late
preterm individuals, it allowed for a more direct assessment of
preterm birth per se (31), and the findings are more widely
applicable given that 80% of individuals are born between 32
and 36 weeks of gestation (39).
Future Work
Longitudinal follow-up of this cohort will establish whether
changes in mass and associations with function persist into
later life. Furthermore, their relation to reduced exercise
capacity (40) and higher blood pressures seen in those born
preterm (41) will be established. If associations exist, then
interventions including postnatal pharmacological approaches
that improve myocardial development during this critical
postnatal window, as demonstrated in animal models (42),
may have long-term health benefits that could therefore be
explored in future human studies. Postnatal nutrition,
including exclusive human milk consumption and intrave-
nous lipids, has already been shown to predict adult cardiac
size and function (6,7), although not cardiac hypertrophy, in
those born preterm. It is possible that exclusive human milk
diets may be a particularly beneficial area of research focus for
improving cardiac development and reducing long-term risk
in preterm offspring (6).
Limitations
In the neonatal cohort, because of our stratified recruitment,
the incidence of maternal hypertension was similar between
groups (Table 1), which means that our term “control” group
does not represent true normative data. However, it does limit
the extent to which hypertension is acting as a confounding
factor. In addition, because of the additional data sets from
uncomplicated pregnancies in the fetal cohort, there was a
greater proportion of hypertensive pregnancies in the preterm
group when modeling cardiac growth trajectories, which needs
to be taken into account during interpretation. Finally, only 55
infants had both antenatal and postnatal measurements
performed when ideally each fetus should have been tracked
across gestation and into postnatal development. However,
data comparing the full and neonatal cohorts suggest minimal
differences between them, and all mothers were selected from
the same population setting.
Another potential limitation is our use of automated
software to derive measures from single 4-chamber views.
Neonatal and fetal echocardiography is technically challen-
ging, although four-chamber views can be acquired in most
fetuses by 13 weeks of gestation (43). Therefore, our use of a
single plane increased data capture and allowed standardized,
repeated measures from gestation through postnatal develop-
ment. Assumptions about ventricular geometry means that
absolute mass measures should be interpreted with caution.
However, as similar assumptions were made across the cohort
with good reproducibility, between-group differences are
likely robust. Furthermore, our assumptions are supported
by computational modeling of shape and findings replicated
from linear wall thickness measures. The complex shape of
the RV makes analysis difficult, but single plane measure-
ments have been reported (16) and, as there are limited
reports of RV changes, our findings add novel data to the
literature.
Conclusions
Preterm infants undergo a disproportionate increase in
ventricular mass in the postnatal period, over and above
what would be expected in utero, which is associated with
cardiac dysfunction. These changes reflect those observed in
experimental models of preterm delivery and in adults who
were born preterm. The postnatal period appears to be a
critical period of cardiac development and may offer a
window for interventions to prevent long-term cardiovascular
consequences of preterm birth.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at
http://www.nature.com/pr
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